SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-20-009069
Filing Date
2020-08-13
Accepted
2020-08-13 16:26:04
Documents
60
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT vtgn10q_june302020.htm 10-Q 1569393
2 MATERIAL CONTRACTS ex10-2.htm EX-10.2 610764
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-1.htm EX-31.1 12335
4 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF ex31-2.htm EX-31 13213
5 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE ex32.htm EX-32 6882
6 IMAGE ex10-2000000.jpg GRAPHIC 6594
  Complete submission text file 0001654954-20-009069.txt   4376267

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT vtgn-20200630.xml EX-101.INS 479456
8 XBRL TAXONOMY EXTENSION SCHEMA vtgn-20200630.xsd EX-101.SCH 30023
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtgn-20200630_cal.xml EX-101.CAL 50119
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtgn-20200630_def.xml EX-101.DEF 92548
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtgn-20200630_lab.xml EX-101.LAB 191466
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtgn-20200630_pre.xml EX-101.PRE 160702
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Filer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37761 | Film No.: 201099692
SIC: 2834 Pharmaceutical Preparations